Literature DB >> 26826904

Outcome and risk of recurrence for endoscopic resection of colonic superficial neoplastic lesions over 2 cm in diameter.

Giovanna Margagnoni1, Stefano Angeletti1, Giancarlo D'Ambra1, Cristiano Pagnini1, Maurizio Ruggeri1, Vito Domenico Corleto2, Emilio Di Giulio1.   

Abstract

BACKGROUND: Large colorectal superficial neoplastic lesions are challenging to remove. This study aimed to assess the outcomes of routine endoscopic resection of large (≥2 cm and <3 cm) and giant (≥3 cm) lesions.
METHODS: From 4587 endoscopic resections, 265 (5.7%) large and giant lesions were removed in 249 patients. We retrospectively analyzed 125 patients (141 endoscopic mucosal resection, 73 large and 68 giant lesions) with a follow-up of 6-12 months. Rate of en bloc and piecemeal resection, recurrence and risk factors were analyzed.
RESULTS: En bloc was performed in 92 cases (65.2%) and piecemeal resection in 49 (34.8%). A complete endoscopic resection was achieved in 139 cases (98.5%) with radical resection in 84/139 cases (60.4%). Argon plasma coagulation was applied in 18/141 lesions (12.8%). A recurrence occurred in 16/139 lesions (11.5%). The risk of recurrence at one year was significantly higher for giant than large lesions (p=0.03). The recurrence risk was higher in treated than in non-argon plasma coagulation treated lesions (p=0.01).
CONCLUSIONS: endoscopic mucosal resection is a safe and effective routine treatment for large superficial neoplastic lesions. The risk factors for recurrence include giant size, non-protruding morphology, piecemeal technique and argon plasma coagulation.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  En block; Endoscopic mucosa resection; Piecemeal; Polyps; Superficial neoplastic lesions

Mesh:

Year:  2015        PMID: 26826904     DOI: 10.1016/j.dld.2015.10.006

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  3 in total

1.  Adenoma recurrence after endoscopic mucosal resection: propensity score analysis of old and new colonoscopes and Sydney recurrence tool implementation.

Authors:  Daniela Guerrero Vinsard; Pujan Kandel; Lady Katherine Mejia Perez; Russell L Bingham; Ryan J Lennon; Timothy A Woodward; Victoria Gomez; Massimo Raimondo; Ernest P Bouras; Michael B Wallace
Journal:  Endosc Int Open       Date:  2018-02-07

2.  Endoscopic mucosal resection (EMR) versus endoscopic submucosal dissection (ESD) for resection of large distal non-pedunculated colorectal adenomas (MATILDA-trial): rationale and design of a multicenter randomized clinical trial.

Authors:  Y Backes; L M G Moons; J D van Bergeijk; L Berk; F Ter Borg; P C J Ter Borg; S G Elias; J M J Geesing; J N Groen; M Hadithi; J C H Hardwick; M Kerkhof; M J J Mangen; J W A Straathof; R Schröder; M P Schwartz; B W M Spanier; W H de Vos Tot Nederveen Cappel; F H J Wolfhagen; A D Koch
Journal:  BMC Gastroenterol       Date:  2016-05-26       Impact factor: 3.067

3.  Treatment strategy for local recurrences after endoscopic resection of a colorectal neoplasm.

Authors:  Sayo Ito; Kinichi Hotta; Kenichiro Imai; Yuichiro Yamaguchi; Yoshihiro Kishida; Kohei Takizawa; Naomi Kakushima; Noboru Kawata; Masao Yoshida; Hirotoshi Ishiwatari; Hiroyuki Matsubayashi; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2018-07-24       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.